Archive for the ‘Psychological Aspects’ Category

Exploring the Controversial Concept of Chronic Lyme Disease

 Approx. 4 Min.

Exploring the Controversial Concept of Chronic Lyme Disease

Contagion_Live
Published on Jul 20, 2018

Samuel Shor, MD, FACP, (past ILADS president) explores the controversial concept of chronic Lyme disease and the role of antibiotic stewardship in treatment programs.

To see the controversy in action:

 Approx. 8 Min.
Contagion_Live
Published on Aug 21, 2017

Lyme Disease: Theories for Longer-Term Manifestations

Panelists Peter L. Salgo, MD; Leonard Sigal, MD; Samuel Shor, MD, FACP; Robert C. Bransfield, MD, DLFAPA; and Patricia V. Smith outline potential theories for longer-term clinical manifestations that have a less clear-cut link to Lyme disease

Proof of borrelia persistence:  https://madisonarealymesupportgroup.com/2015/09/19/proof-of-borrelia-persistence/

https://madisonarealymesupportgroup.com/2017/08/18/drexel-prof-lyme-persists/

https://madisonarealymesupportgroup.com/2018/04/17/persistent-borrelia-infection-in-patients-with-ongoing-symptoms-of-lyme-disease/   (More links within article)

http://norvect.no/230-peer-reviewed-studies-show-evidence-of-persistent-lyme-disease/

https://www.ilads.org/wp-content/uploads/2018/07/CLDList-ILADS.pdf

https://madisonarealymesupportgroup.com/2016/08/09/dr-paul-duray-research-fellowship-foundation-some-great-research-being-done-on-lyme-disease/   The work of Dr. Elizabeth Burgess DVM PhD in 1990 showed that dogs infected with LD were transmitting and infecting female dogs through sexual transmission, proof in humans is lacking. Pathologist Alan McDonald found B. burgdorferi and B. mayonii in the testicle and brain of a man who had been treated nearly continuously on antibiotics for the last seven years of his life. Grier states the case for sexual transmission is stronger than ever.

https://madisonarealymesupportgroup.com/2018/06/19/33-years-of-documentation-of-maternal-child-transmission-of-lyme-disease-and-congenital-lyme-borreliosis-a-review/

https://madisonarealymesupportgroup.com/2018/06/28/the-science-isnt-settled-on-chronic-lyme/

This recent study shows dead Lyme debris causes inflammation:

https://madisonarealymesupportgroup.com/2018/07/17/study-shows-dead-lyme-debris-persists-in-cns-despite-antibiotics-and-causes-inflammation/

_______________

Two points for consideration:

  • “The absence of evidence is not the evidence of absence”
  • Would you deny antibiotic treatment to those suffering with chronic tuberculosis, chlamydia, or bladder infections?

Study Shows Magnesium Treats Depression Better Than Antidepressant

https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/393025281&color=006341“>

This story is produced and presented by The University of Vermont Medical Center

Globally, more than 300 million people of all ages suffer from depression. It’s the leading cause of disability and a major contributor to the overall global burden of disease. Yet treatment for depression can be limited by effectiveness, cost, availability and side effects. Now, a new clinical trial done at the University of Vermont shows that magnesium may be a safe, effective, and less expensive treatment option for mild to moderate depression. Read or listen to our interview above with one of the leaders of this clinical trial, Emily Tarleton, PhD, RD, CD. She is a Bionutrition Research Manager at the University of Vermont’s Clinical Research Center.

Your clinical trial finds a link between depression and magnesium intake. What have you discovered through your work?

Emily Tarleton: We were following up on some cross-sectional and prospective trials. I found an inverse association between magnesium intake and depression, so we conducted a randomized clinical trial with the aim of determining whether supplemental magnesium really does influence symptoms of depression. And we found that over a six-week period of time, symptoms of both depression and anxiety improved significantly. And this was the case regardless of age, gender, baseline severity of depression, baseline magnesium status, or use of other treatments for depression, such as counseling or antidepressants. And we also found that it was really well-tolerated, and a majority of participants indicated that they would use it in the future, which was one of our main outcomes.

So for anyone who is a little bit new to the research world, what exactly is a randomized controlled trial?

Emily Tarleton: Right. So a randomized controlled trial is a trial in which we … in this case, we were comparing people to themselves, so we gave them a treatment for the six weeks, which in this case was the magnesium supplement, and then we followed them the same way for another six weeks without the magnesium supplement so we could compare how they responded while on the supplement, but also what happened while they were off of the supplement. And it’s randomized because they either started the supplements at week one or at week seven, so it’s sort of a crossover design.

And this was just here in Vermont? Are these Vermonters who participated?

Emily Tarleton: Yes. We started small for this trial, and we used outpatient primary care clinics to recruit from through physicians and people had to have a baseline of still suffering from depression, so people who are currently experiencing symptoms, and we were able to do our study over the phone for the most part, and it was really … people really liked the opportunity to try something new.

And magnesium is something that you can just buy, right, in the store? It’s over the counter?

Emily Tarleton: Right. And magnesium is also found in a lot of foods that we eat, so the reason we don’t tend to get enough is because it’s the healthy food people don’t really like to eat a lot of, so things like green leafy vegetables and whole grains and nuts and legumes. As a society, unfortunately those aren’t foods that we over-consume- so people tend to not get as much magnesium as they should.

Is this something where, outside of the world of mild to moderate depression, anyone could benefit from?

Emily Tarleton: Yes. Because magnesium is in these healthy foods, certainly anybody would benefit from consuming more of those foods in general. But magnesium has also been found to help with other chronic diseases. It’s been associated with cardiovascular disease and diabetes. People with migraines sometimes take magnesium. Also the big connection is with muscle cramping, so some people who tend to have a lot of muscle cramping, leg cramps, will take magnesium and that seems to help for them as well.

In general there aren’t a lot of great studies or randomized clinical trials on showing a cause and effect of magnesium in these uses, but their research is ongoing.

In this study, and I just want to get a better understanding for what some of these participants went through, how often did they have to take the magnesium?

Emily Tarleton: We had them take the tablets every day. We suggested they take two in the morning and two in the evening just to avoid that stomach upset. Some people took all four at once, and that was fine for them. Other people liked to split it up. It really didn’t seem to make a difference.

Another thing we found was that the effect was significant regardless of overall compliance, so at the end of the study we did a pill count to see how compliant they were with taking the supplements, and the lower the compliance, people still had a good reaction, a good decrease in their symptoms. So, in a future study we could look at using even less of the supplement.

Are there plans for a future study?

Emily Tarleton: We would love to do another study. There’s lots of … of course, we’d like to do a longer-term, bigger randomized controlled trial with a more diverse population to really show that this happened. We didn’t really have enough people. While I mentioned that we saw the effect regardless of age and gender and all those other little sub-studies, we didn’t really have enough people to really prove that or not, so we’d love to do a bigger study to show if there is a difference by race or gender. Age is another big one we’d like to look at.

So as we talked about a little bit earlier, the treatment for depression is complex. It can be limited by cost, availability. There are side effects. It’s a very complicated thing. What do you think … and I realize that the study and the research is somewhat in its infancy. What do you think is the promise of magnesium as a treatment for people?

Emily Tarleton: Yeah. As you mentioned, we’re just getting started and even within our study, magnesium of course like any other treatment didn’t work for everyone. But, because of the positive effects that we saw and because they worked quickly with very few side effects, it can be an option that patients can explore with their primary care or any other healthcare provider that they’re seeing. There really is little risk to taking magnesium because, like I said, the side effects are few. We also saw the change in symptoms of depression within two weeks of taking the supplements, so if within two weeks you don’t see … you’re not feeling any better or you happen to be even feeling worse, you can certainly stop taking them. Because it’s a mineral, it doesn’t stay within the body for a long period of time. After a day or two, any extra magnesium you have will be flushed out. If for some reason you feel like, “Oh, I don’t know. For some reason it’s making me feel worse,” it comes out of the body really quickly as well.

As I mentioned, we were able to decrease those side effects just by changing the timing of the dose or decreasing the dose to less than we had originally started at. It’s also inexpensive. You mentioned the cost. About a month’s supply of the magnesium chloride that we used in the study is only about $12 to $14 a month. And over-the-counter so you can get it on Amazon.

Another aspect people liked about the magnesium was the lack of stigma associated with taking it. Some people just really don’t want to start an antidepressant for that reason. And you know, even people who start antidepressants oftentimes are put in a tough situation where they may be feeling a little bit better, but not where they want to be.

Now they’re in a position where they need to either increase their dosage or add another medication increasing those risks of side effects, or they’re left with the other option which is stay where they are and not feel as good as they wanted to. That’s just not a great position to be in. We did have people in our study that were already taking an antidepressant and we did see that there might be what we call this adjunct relationship where the magnesium actually helps the antidepressant work even better. And there are a couple of other studies to support that idea.

This is another direction we can certainly go in. It could be an option in that sense too like, “Hey, I just really don’t want to risk increasing my side effects,” or “I just really don’t feel I’m feeling at the point where I want to start an antidepressant yet.” Magnesium might be an option.

For people who are maybe feeling depressed and who haven’t seen their doctor yet or haven’t really talked to anyone yet, what’s the step for them? Is this something where they go to the grocery store and pick some of this up? What would they do next?

Emily Tarleton: Magnesium does actually interact with some medications, so you would want to talk to your healthcare provider before starting it. But, as we mentioned, it’s also found in really healthy foods, and there are some theories that just certain nutrients in combination might help with depression as well. And we’ve seen studies on things like fish oils, vitamin B. We’ve looked at vitamin D as well. Zinc, folic acid, all these different nutrients people have found some sort of association as well. Eating healthy foods that have all of these nutrients may help, may be beneficial, and may help you feel good in general just because you’re taking care of yourself in that sense.

We’ve talked about the study a lot, but I’m also kind of fascinated by your title. You’re a Bionutrition Research Manager. What are some of the other things you work on in your role here?

Emily Tarleton: Yeah. The Clinical Research Center is located on Shepardson 2 at the main hospital, and we do inpatient and outpatient research and really, any investigator within the UVM or UVM Medical Center community can utilize our services, and we have a metabolic kitchen, as well, that we can do food trials.

What’s a metabolic kitchen?

Emily Tarleton: It’s a kitchen that is specific to research where we create these very controlled meals. Whether an investigator wants to control for a certain nutrient or they want to just control the overall calories people are consuming at a given time. So we do some long-term feeding trials where sometimes we’re controlling the fatty acid content of the food, sometimes we’re looking at the different effects of dairy, sometimes we’re looking at the effects of glucose. So we’re involved in various studies throughout the community, and it’s really exciting to be involved at this level and sort of get to see the results of some of these other trials.

Is there anything else that you found in your research that you think it would be helpful for our listeners to hear?

Emily Tarleton: One of the things we found was that, as I alluded to, the US adult population really doesn’t consume enough magnesium, and so we took a closer look at this and tried to figure out some reasons why that might be. There have been changes in agricultural processes over the last century that has actually decreased the amount of magnesium in the soil, therefore there’s less magnesium absorbed by the plants and the vegetables that we eat. That’s one reason.

That also means that we have to increase the amounts of those vegetables to get the same amount of magnesium, but what we found was that our intake of vegetables has actually gone down slightly over the past couple of decades. So we’re getting less in the plant to begin with and then we’re consuming less of those vegetables which isn’t a great combination. Those are sort of changes in the way our consumption patterns are as adults. We’ve also just decreased our whole grains and we’re eating more processed vegetables, more processed grains and refined oils, which all have less magnesium as well. Socioeconomic status also plays a role in magnesium consumption, so those that are at the lower end of the socioeconomic status, they tend to not only eat more processed and refined foods, they also are less likely to take a supplement in general and a supplement that contains magnesium.

Is that because of cost or-?

Emily Tarleton: Usually it’s cost. Yeah. And just a side note that many multivitamins don’t have magnesium in them to begin with so if you’re taking a general multivitamin, you can look at the bottle but not all of them contain magnesium. You can look for one that does have some, and usually it’s a very small amount even if it does.

Finally, there’s also issues with absorption and excretion so we have to absorb the magnesium after we consume it, whether it’s from food or a supplement. And then we have to not excrete it all. We have to maintain some of that absorption. Things like alcohol consumption, smoking, medications and several chronic diseases actually affect the absorption or the excretion of magnesium. As we’ve seen an increase in things like diabetes over time, it’s actually known that people who have diabetes absorb less magnesium. There’s research ongoing in these areas, as well. There are many reasons why we’re not getting enough, and this is not only in the US but in other countries as well. They’ve seen the same trend.

We’ve just been talking with Emily Tarleton. She’s a PhD and a registered and certified dietician at the University of Vermont Medical Center. She’s a Bionutrition Research Manager at the University of Vermont Clinical Research Center. If you want to learn more about her studies and other things happening here, please visit uvmhealth.org/medcenter.

If you want to learn more about clinical trials and research currently happening at the University of Vermont and the University of Vermont Medical Center, visit our website.

Members of the editorial and news staff of the USA Today Network were not involved in the creation of this content.

______________

**Comment**

It’s pretty common for Lyme/MSIDS patients to suffer with depression at some point in their journey.  There are many potential reasons for this – including pain, isolation, fear, and loss of control of nearly everything.  I personally found a direct correlation between how I felt physically and how I felt mentally.  Thankfully good, appropriate, effective treatment of antimicrobials resolved this and I never had to take anything for depression.  (And my treatment wasn’t 21 days of doxycycline!)

For Lyme treatment ideas:  https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/

 

 

Recover From Brain Fog & Lyme Disease Naturally

https://www.linkedin.com/pulse/recover-from-brain-fog-lyme-disease-naturally-gary-blier/

Recover From Brain Fog & Lyme Disease Naturally

Published on June 26, 2018
Gary Blier
Founder, Advanced Cell Training

When most people think of Lyme disease, it conjures up thoughts of rashes, flu-like symptoms, and joint pain. However, there are a significant number of Lyme sufferers who also experience brain fog: agonizing neurological symptoms that leave them feeling drained, irritable, confused, and cognitively lagging.

Brain fog is one of the most common psychiatric manifestations of Lyme Disease. In fact, it’s estimated that 70% of individuals affected by Lyme show signs of cognitive decline or memory loss.

While you may be familiar with brain fog within the Lyme community, you may not be aware of what it is or why it happens. We’ll break it all down for you in this article and provide you with natural solutions you can carry out at home to lift the fog that robs you of a clear mind.

What is Brain Fog?

Brain fog is a term given by those whose brain function is underperforming compared to a normal, healthy brain. It can range from a mild case of “cloudiness” to a more severe case that makes it difficult to perform basic tasks.

Brain fog symptoms include:

Memory loss
Slowed processing
Difficulty thinking or making decisions
Poor concentration
Mood swings
Confusion
Sleep disturbances
Decreased problem-solving abilities
Easily overwhelmed
Low energy or fatigue
Headaches
Depersonalization or dissociation (i.e., loss of emotional connection to others and life)
Other brain fog indicators may include feeling fuzzy-headed, unmotivated, melancholy, or irrational for no apparent reason. It’s also not uncommon for anxiety and depression to accompany brain fog, especially in cases of prolonged illness.

Additionally, brain fog symptoms can wax and wane during periods of high stress, exposure to electromagnetic frequencies and overly stimulating environments, hormonal changes, and during a herxheimer reaction. Symptoms can even intensify with certain moon cycles.

Your Brain on Lyme

Scientists are still trying to understand Lyme disease and how it affects the brain, but several studies have already concluded that Lyme bacteria can impact every aspect of the brain. Medical experts also agree that Lyme and coinfections cause the brain to swell, which can result in neurological or neuropsychiatric symptoms such as brain fog.

One of the most common causes of brain fog are the Lyme pathogens themselves, otherwise referred to as spirochetes. These corkscrew-shaped bacteria deeply embed themselves inside tissues, neurons, and cells. They can cross over the blood-brain barrier and wreak havoc on brain receptors and neural pathways.

When these pathogens die off, they excrete harmful endotoxins and exotoxins that inhibit brain function. If you do not detox properly, these toxins can accumulate and cause brain fog or damage brain tissue. The very presence of such toxins trigger the immune system to go into hyperdrive, releasing more cytokines into the blood, fueling inflammation within the brain and body. Cytokines are small proteins that are instrumental in cell signaling.

To overcome Lyme disease and brain fog, it’s crucial to address all underlying inflammation by making modifications to one’s diet and lifestyle.

Natural Brain Fog Recovery Tips

Get on the road to recovery from Lyme brain fog by taking inventory of the following areas:

Restful Sleep

One of the most significant neurological challenges for people with Lyme is insomnia. More than just a frustrating symptom, disturbed sleep patterns can interfere with healing by damaging the immune system, allowing toxins or pathogens to take root in the body. Insufficient sleep can also raise cytokine chemicals and quinolinic acid in the body that can lead to inflammation and worsen neurological symptoms.

Getting adequate sleep is key to Lyme recovery. Remember, it’s not just about the hours you clock every night, but also the quality of sleep that matters. Your brain and immune system do most of their healing when you are in a deep sleep, so it’s advised to get sleep around 10:00 pm and wake after about 7-8 hours of good sleep.

Need extra help in this department? Ask a medical practitioner about checking your hormones or thyroid levels to see what could be preventing you from getting enough zzz’s.

Anti-Inflammatory Diet

To support your brain health, try an anti-inflammatory diet to give your brain and body the nutrients it needs to heal. Buy organic as often as possible because toxic GMOs and pesticides can cause inflammation and put unnecessary stress on your body.

Eliminate these common offenders from your diet: caffeine, alcohol, refined carbohydrates, gluten, and sugar. All of these are enemies of brain fog and can impair brain function. It’s also best to avoid these substances until after your Lyme recovery.

Click here to read a great article on the top 15 anti-inflammatory foods that can transform your health:  https://draxe.com/anti-inflammatory-foods/

Also, cut out neuro-inflammatory saturated fats and instead up your intake of good or monounsaturated fats. Olive oil, nuts, avocado, and some types of fish have been shown to enhance memory and cognitive function, according to Harvard Medical School.

De-Stress Your Brain

High levels of cortisol, the body’s “stress hormone” have been linked to brain fog. Chronically elevated cortisol can disrupt your symphony of hormones that work intrinsically to keep your body in check. When one hormone falls too low, another one overcompensates to restore harmony.

Routinely check your cortisol levels (preferably via a saliva test) to ensure your levels are in balance. Actively pursue activities that reduce stress and declutter your mind, whether it be meditation, prayer, music, or your favorite hobby. Give yourself permission to unplug from the grid and relax.

Detox, Detox, Detox

Brain fog is often a sign of built-up toxins–Lyme, mold, parasites, or yeast–in the blood and intestines. Consider infrared sauna sessions, or doing light exercise or yoga to stimulate your lymphatic system. Get those toxins moving out of your body!

You may also speak to your healthcare providers about supplements you can take to support your detox pathways. Bentonite clay, activated charcoal, and juice cleanses are generally safe options for cleaning out the sludge.

Another way to help flush toxins out is to stay well-hydrated throughout the day. Multiply your body weight by 67%. The resulting number is the number of ounces of water you should drink daily. For example, a 100-pound person would need 67 ounces of water. Divide that by 8 – the number of ounces in a glass of water – and the result is roughly 8 glasses of water per day. Most of us fall far short of this amount.

Self-Healing for Lyme Disease and Brain Fog

You might also need extra support recovering from Lyme disease and brain fog. Advanced Cell Training (ACT) offers a self-healing program that enables your body’s own awesome ability to kill microorganisms – even in the brain. With ACT, you can train your own immune system to respond appropriately to spirochetes, parasites, and coinfections. This simple training process has helped thousands over the last 20 years overcome health issues. Basically, we point out where your body is going wrong and show it how to self-correct and get things back on track.

For more on ACT:  https://advancedcelltraining.com

 

Suicide Poses a Complicated Risk in Those With Infectious Diseases

https://www.contagionlive.com/news/suicide-poses-a-complicated-risk-in-those-with-infectious-diseases

Suicide Poses a Complicated Risk in Those with Infectious Diseases

JUL 02, 2018 | JARED KALTWASSER

A diagnosis of an infectious disease can be devastating for patients. Even as more effective treatments become available for infections such as HIV and hepatitis C, patients who receive a positive diagnosis must prepare for significant life changes and new burdens.

As physicians struggle to keep up with the latest treatments and therapeutic research, a growing body of evidence is highlighting another problem closely tied to infectious disease: suicide.

The first half of this month (June) was marked by a pair of high-profile suicides, prompting a national discussion about risk factors and prevention. When it comes to infectious diseases, suicide is a major problem, but one that is difficult to address because its cause is difficult to isolate.

“It gets very messy and hard to pinpoint an exact cause [of suicide],” said Travis Salway, PhD, a post-doctoral fellow at the University of British Columbia’s School of Population and Public Health and the British Columbia Centre for Disease Control.

The problem can be related to psychological and psychiatric factors, stress, pain, and chemistry. And sometimes, it can even be linked to the treatment for the underlying infection.

Though the issue is complicated, the statistics are clear. Salway’s research, which focuses on health disparities for LGBT individuals, found that nearly 1 in 4 (22%) gay and bisexual men who are HIV-positive reported suicidal ideation within the past year. Five percent of respondents to Salway’s survey reported a suicide attempt within the past year.

Another 2010 study found that although suicide rates dropped significantly among the HIV-positive population after the introduction of highly active antiretroviral therapy (HAART), the HIV-positive suicide rate was still 3 times higher than the general population.

However, the issue of suicidality among patients with infectious diseases is not just an HIV story.

Reports have shown increases in depression and suicidality among patients with hepatitis C (HCV) infections, and among those who received interferon therapy.

Contagion® Editorial Advisory Board member, Robert C. Bransfield, MD, a psychiatrist who has studied links between infectious disease and suicidality, said interferon therapy marked something of a turning point. Although it didn’t cause depression or suicidality in every patient, the occurrence was significant enough to cause people to look more closely.

“You’re activating the immune system. Immune activation helps fight the infection, but immune activation can also alter neurochemistry and make people feel suicidal,” Dr. Bransfield said. “That was the first time there was a drawing of a connection that there’s something there.”

More recently, Dr. Bransfield has been studying the relationship between Lyme-associated diseases and suicide. Last year, he published a study estimating that at least 1,200 people in the United States with Lyme-associated diseases commit suicide each year. That’s out of a total of 40,000 documented suicides (it is believed the number could be significantly higher if undocumented or poorly documented suicides were added).

Why the apparent link between infectious disease and suicidality, especially when HCV, HIV, and Lyme disease can all be treated with increasingly effective medications? Dr. Bransfield said there are multiple reasons.

In some cases, the issue may have to do with the stress of chronic pain, the potential to lose or miss work, or social stigma.

“That could be a psychological reason,” he said. “But separate and apart from that, there’s a physical thing that pushes people to suicide.”

In fact, a growing body of research has suggested that inflammation is linked to suicide.

“When you’re in a pro-inflammatory state, the risk of suicide is greater,” shared Dr. Bransfield.

Inflammation sets in motion a chain reaction, disrupting the kynurenine pathway, which leads to an increase in quinolinic acid.

“Quinolinic acid then works on the N-Methyl-D-aspartic acid (NMDA) site, and the NMDA site is a receptor in the nervous system,” he said. “When it hits that, it can make someone suicidal.”

That knowledge opens up significant new areas of research, but it also forces something of a change in the mentality of the medical community.

It forces us to not be so fragmented within our specialty,” Bransfield explained. “Psychiatrists have to think of other specialties and general medicine and keep current, but so do infectious disease doctors. Infectious disease doctors can’t just view themselves as the authority in their field without thinking about how their fields connect to other fields, such as psychiatry.”

Aside from the physiological links between infectious disease and suicide, Dr. Salway said the issue is further complicated by the fact that many patients in some of the highest-risk categories have multiple risk factors for suicidality.

“We know that factors like loneliness or poor self-esteem, substance abuse, exclusion from your family, seem to be associated with the sexual behaviors that transmit HIV,” he said. “There tends to be a clustering of health problems.”

The idea that multiple risk factors are often at play, is known as syndemic theory. Proponents of syndemic theory argue for a more holistic approach and acknowledging that a patient may have had significant issues and risks for suicide and depression long before they actually contracted HIV.

The theory can be helpful for physicians because it emphasizes areas where they can make a difference.

“Unfortunately, in general practice even in high-risk populations, it’s remarkably difficult to identify people who are imminently suicidal,” explained Dr. Salway. “We don’t have the screening tools to know who needs to be provided immediate care.”

By thinking holistically, physicians can reduce the risk of suicide in HIV-positive patients by addressing other risk factors.

“The current recommendations are actually to bolster the options for things like substance use treatment, depression treatment—things that we know often go hand-in-hand with suicidality,” he said.

Whenever he presents his findings, Dr. Salway finds providers are eager to try and address the problem of suicidality.

“It’s not that they’re not concerned or compassionate about [suicide prevention among patients with HIV], and some are very well aware of it,” he said. “But, we do have a gap in telling physicians how to respond to it. That’s hard to do without better tools around suicide prevention, generally.”

In the clinic, Dr. Bransfield said physicians should not be afraid to ask patients about suicidality, something that often doesn’t happen.

“You don’t hurt anyone by asking,” he said. “You don’t plant the idea there.”

He added that physicians ought to do a better job of reading literature from other specialties. “I think it’s good for infectious disease doctors to brush up and get more current with their knowledge of psychiatry,” he said.

Another way to help, but one that requires resources from public health agencies, is better access to care. A 2017 study in The Lancet found HIV-positive men, in particular, are at a higher risk of suicide (twice the rate of the general population). However, the rate was 5 times higher during the first year after diagnosis, suggesting that treatment and the possibility of controlling the disease long-term can have a positive impact.

“These findings highlight the importance of prompt diagnosis and linkage to care as major public health interventions to reduce premature mortality,” wrote Sarah Croxford, MSc, of Public Health England, and colleagues. “HIV testing should be further expanded outside traditional settings to reach vulnerable populations and patients supported across the HIV care pathway.”

Dr. Salway added that support groups and community organizations can also play a role. HIV support groups, for instance, can help foster conversations about mental health, encouraging people to be more open about their struggles.

Though the challenge is complicated, Dr. Salway is gratified that people who know about the issue seem to want to fix it.

“I think people will start to push this along,” he said. “I’m optimistic.”

____________

**Comment**

Great article.  I agree whole-heartedly about the importance of a support network such as a support group.  If you’ve never considered that before, please do.  You can find Lyme/MSIDS support groups by going to the right side of the website and scroll down to “Lyme Resources,” and by clicking onto “Find a Lyme Support Group.”  It is so cathartic to be in a room full of people who “get it.”  You can also ask a lot of questions and become educated.

I also whole-heartedly agree about the need for medical professionals to “cross train,” as the integration of body, mind, and spirit can never be overestimated.  Since Lyme/MSIDS can be anywhere in the human body, it’s imperative medical professionals are open-minded about manifestations and realize that once it gets into the central nervous system, cognitive and psychological manifestations can be rampant.

A great example is that a prominently experienced LLMD in Wisconsin states 80% of his PANS/Autistic patients also have Lyme/MSIDS.  This article shows how one doctor connected the dots just in time for two patients who fell through the cracks:  https://madisonarealymesupportgroup.com/2017/10/01/panspandas-steroids-autoimmune-disease-lymemsids-the-need-for-medical-collaboration/

Right now, “Brain on Fire,” is showing on Netflix:  https://madisonarealymesupportgroup.com/2018/06/26/netflix-currently-showing-brain-on-fire/

It is also a book:  https://www.nytimes.com/2012/12/23/books/review/brain-on-fire-by-susannah-cahalan.html

I highly recommend both.

https://madisonarealymesupportgroup.com/2018/06/14/depression-the-radical-theory-linking-it-to-inflammation/  Accepting that some cases of depression result from infections and other inflammation-causing disorders of the body could lead to much-needed new treatments, he argues.

https://madisonarealymesupportgroup.com/2018/01/18/depression-not-caused-by-chemical-imbalance/

https://madisonarealymesupportgroup.com/2018/03/09/aggressiveness-violence-homicidality-homicide-lyme-disease/

https://madisonarealymesupportgroup.com/2018/04/12/psychiatric-drugs-create-violence-suicide-school-shootings-other-acts-of-senseless-violence/

 

Cat Scratch Disease in a 1.5 Year Old Girl – Case Report

https://www.ncbi.nlm.nih.gov/m/pubmed/29936799/

Cat Scratch Disease in a 1.5-year-old girl – Case report.

Karski J, et al. Ann Agric Environ Med. 2018.

Abstract
INTRODUCTION: The paper is a case report presenting Cat Scratch Disease (CSD) in a 1.5-year- old girl. Bartoneloses, including CSD, are a group of infectious diseases which are rarely detected, therefore there are no statistical data concerning the aetiology, and the incidence of CSD noted in Poland is low in comparison with other European countries.

OBJECTIVE: The purpose of the paper is to discuss several problems related to CSD.

MATERIAL AND METHODS: A 1.5-year-old girl who was seen in hospital for the sparing use of her left arm when crawling. X-rays showed osteolytic lesions which radiologists described as multi-ocular cyst or infection. As neither clinical examination nor laboratory investigations found pathological signs, the patient was followed-up on an ambulant basis. Repeated x-ray taken 4 weeks later showed increased periosteal proliferation accompanied by pain. The baby was admitted to the Clinic but additional investigations found no pathologies. The baby was consulted by a rheumatologist and haematologist; however, they did not facilitate a definitive diagnosis. As the baby developed, because of a thickening of the soft tissues on the dorsal side of the distal epiphisis in the forearm the doctors decided to inspect the condition operatively. Macroscopic examination found brownish granulated tissue. Suction drainage was inserted and a tissue sample was tested for aerobic and anaerobic bacteria, tuberculosis and borelliosis. The test results were negative. The baby was in good condition, was not pyrexial and suffered from less pain. The diagnostics was further expanded and the baby tested for yersinia, chlamydia, tuberculosis and bartonella, i.e. CSD. The postoperative wound healed soon and radiological bony lesions began to resolve. After a month, we received a positive bartonella test result, the baby tested positively for Bartonella henselae IgG class, which confirmed past or active infection of CSD. A repeated test for B. henselae taken 6 months later showed a lower level of antibodies.

CONCLUSIONS: It should be remembered that CSD, which is an extremely rare infection, can be diagnosed despite mediocre clinical and radiological manifestations. Thus, in the case of infections of unexplained aetiology and mediocre manifestations diagnostics should include testing for Bartonella henselae.

PMID 29936799 [ – in process]

_______________

**Comment**

There is little to no statistical data on Bartonella, that’s for sure, but it’s far from a rare infection & it is far from benign, in fact I would go as far to state it is prolific and devastating.  

Please note the finding of granulated tissue.  Bartonella is primarily a vascular disease and causes all sorts of bizarre symptoms – including nodules on the shins and painful soles of the feet; however, please do not underestimate the cognitive/psychological symptoms of this disease (anxiety, anger, suicidal thoughts).  It can also cause:  aseptic meningitis, neuroretinitis & other vision problems, lymphadenopathy (swollen lymph nodes), headaches, seizures, heartburn, abdominal pain, skin rash, gastritis, duodentis, mesenteric adenitis, myocarditis & endocarditis, and cysts.  

Authorities are still squabbling over whether ticks transmit this or not, but we know for sure spiders and other arachnids do as well as cat scratches, biting flies, fleas, needle stick transmission in veterinarians as well as drug users.  And just because something can’t be seen/proven in ticks, doesn’t mean it doesn’t happen.  Frankly, all it shows is the science is lagging and this is a fastidious organism which is hard to detect.  All I know is that nearly every Lyme/MSIDS patient I work with has Bart.  So either the tick transmits directly OR a previously asymptomatic case is triggered upon getting a tick bite.  Either way, WE GOT IT and it needs to be considered in each and every Lyme/MSIDS patient.

For more on Bartonella:  https://madisonarealymesupportgroup.com/2016/01/03/bartonella-treatment/  (Checklist and treatment options within this link)

Fifteen species of gram-negative aerobic Bartonella are known to infect humans; however Dr. Ricardo Maggi’s statement is quite telling, “This case reinforces the hypothesis that any Bartonella species can cause human infection.”

Dr. Mozayeni talks about Bartonella as one of the major co-infections of Lyme disease. It’s more prevalent than Lyme, as there are many more ways to contract the disease (eg. flees, cats). In a study, that Dr. Breitschwerdt and Mozayeni published in The Journal of Emerging Diseases, about 60% of Lyme patients tested positive for Bartonella. Dr. Mozayeni also talks about the importance of looking at Biofilm when treating Lyme, Bartonella etc. as biofilm can harbor many of these microbes and be the cause of many symptoms.

https://madisonarealymesupportgroup.com/2018/05/07/fox-news-bartonella-is-the-new-lyme-disease/

https://madisonarealymesupportgroup.com/2016/08/09/a-bartonella-story/

https://madisonarealymesupportgroup.com/2018/06/12/osteomyelitis-in-cat-scratch-disease-a-never-ending-dilemma-a-case-report-literature-review/

https://madisonarealymesupportgroup.com/2018/04/03/encephalopathy-in-adult-with-cat-scratch-disease/

https://madisonarealymesupportgroup.com/2018/05/09/rheumatological-presentation-of-bartonella-koehlerae-henselae-a-case-report-chiropractors-please-read/  Please note the joint popping with each articulation and continual joint subluxation issue.
Chiropractors need to be told about this. Please educate! Send them this article.  I too had this bizarre popping of the joints with a lot of instability in the knees. Treatment completely ameliorated this issue so treatment is primo important.

https://madisonarealymesupportgroup.com/2018/06/15/fleas-harbor-bartonella-13-days-post-infection-continuously-excrete-bartonella-dna/

https://madisonarealymesupportgroup.com/2018/06/20/northern-southern-ca-cats-have-bartonella-and-rickettsia-proven-by-16s-rrna-next-gen-sequencing/

https://madisonarealymesupportgroup.com/2016/12/29/cardinal-state-bartonella/